Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.705 SEK | -0.13% | -6.32% | +19.90% |
Apr. 08 | Oncozenge AB Appoints Paolo Bossi as Member of the Advisory Board | CI |
Apr. 04 | OncoZenge Announces Read-Out of Positive Stability Data for BupiZenge | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 43.4M 465M |
---|---|---|---|---|---|
Net income 2024 * | -8M -85.71M | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | 3M 32.14M | Net cash position 2025 * | 3M 32.14M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.45
x | P/E ratio 2025 * |
-
| Employees | 2 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 33.97% |
1 day | -0.13% | ||
1 week | -6.32% | ||
Current month | -0.40% | ||
1 month | -13.54% | ||
3 months | -7.38% | ||
6 months | +34.00% | ||
Current year | +19.90% |
Managers | Title | Age | Since |
---|---|---|---|
Stian Kildal
CEO | Chief Executive Officer | - | 23-09-12 |
Michael Owens
DFI | Director of Finance/CFO | 68 | 23-10-11 |
Markus Jerling
CTO | Chief Tech/Sci/R&D Officer | 72 | 21-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christoph Nowak
BRD | Director/Board Member | 38 | 23-09-08 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 3.705 | -0.13% | 10,620 |
24-05-16 | 3.71 | -1.98% | 4,780 |
24-05-15 | 3.785 | -0.39% | 24,848 |
24-05-14 | 3.8 | -1.81% | 31,695 |
24-05-13 | 3.87 | -2.15% | 15,145 |
Delayed Quote Nasdaq Stockholm, May 17, 2024 at 11:08 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+19.90% | 4.05M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- ONCOZ Stock